Invest in Greece while it’s still cheap

Right now, investing in Greece may seem plain mad. But Greece is dirt-cheap. And buying cheap stocks typically pays off in the long run. Matthew Partridge picks the best ways to buy in.

758_MW_P22_Funds

Buy in ahead of the next stand-off

After this summer, investing in Greece may seem less contrarian than plain mad. The market is down by nearly 50% on last year's (it's back at the same level it was three years ago, at the height of eurozone fears). However, fresh elections are due in just over a fortnight's time, with talks on possible debt relief to follow. This means the choice between a substantial write-down of debt, or a euro exit, both of which should benefit the nation in the longer run, cannot be postponed any longer. Meanwhile, surprisingly strong second-quarter GDP data suggest the economy has the potential to recover once the disruption is over.

And from an investor's point of view, Greece is dirt-cheap. It's on a cyclically adjusted price/earnings ratio of just two. For perspective, the next cheapest market (Russia) is on a Cape of just under five, while the UK's is more than 12. The Greek market is also cheap on current measures, trading at a 46% discount to the value of its net assets, compared with a 75% premium for the FTSE 100. Sure, it's not a market to bet the house on. But buying cheap stocks typically pays off in the long run.

If you feel bold, the simplest way in is via an exchange-traded fund (ETF) that follows the Athex 20, the 20 largest Greek companies by market capitalisation. Lyxor ETF FTSE Athex 20 (Paris: GRE) is one option, but the Global X FTSE Greece 20 ETF (NYSE Arca: GREK) is also worth considering. It has a slightly higher management fee of 0.55% (Lyxor's is 0.45%), but it kept trading during the capital controls this year. This is worth remembering if Greece does leave the single currency or has another stand-off with its creditors, then restrictions are likely to be imposed again. The Athex 20 includes everything from a bottling firm to a lottery operator, and has relatively low exposure to banks. But if you want a slightly more diversified ETF, you may prefer the Lyxor UCITS ETF FTSE Atex Large Cap (Paris: INGRE), which covers the 25 largest companies.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Greece's woes have also hit property prices. But if these bottom out with the economy, it could be good for Greece-focused investment trust Dolphin Capital Investors (LSE: DCI), which owns several properties in Porto Heli, including two resorts, golf courses and seafront villas. It trades at six times current earnings.

Dr Matthew Partridge

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.

As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.

Follow Matthew on Twitter: @DrMatthewPartri